8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases and Cancer and Bone Society 2018 Meeting
OVERVIEW
8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases and Cancer and Bone Society Meeting is organized by Oxford Molpharm and will be held during Jun 30 - Jul 03, 2018 at St Catherine's College, Oxford, England, United Kingdom.
Conference Overview (MolPharm):
The 2018 MolPharm Workshop is the 8th in a series that started in 2003. It is intended to provide a basis for understanding the molecular mechanisms of action of drugs known to act on the skeleton, and a rational basis for developing novel therapies in the future, based on some of the remarkable recent advances in the genetics and biology of bone and the musculoskeletal system.
The Workshop is interactive and international, with speakers who are leaders of their fields in academia and industry. The workshop is held at St Catherine’s College, Oxford. This delightful campus setting creates excellent opportunities for productive interactions among all participants.
For those who’ve attended before, you’ll know this means an exceptional meeting which combines cutting edge exciting science with a friendly and supportive atmosphere, and which encourages discussion and collaboration both in and out of the lecture theatre. Interaction between senior international scientists, clinicians and more junior researchers is particularly encouraged.
Learning Objectives:
To gain a better understanding of the molecular mechanisms of action of drugs already known to act on the skeleton
To discuss the rational basis for developing novel therapies in the future
To gain a better understanding of the development of drugs for the treatment of rare and common bone disorders
Conference Overview (CABS):
The primary mission of CABS is to formally run the cancer-induced bone disease (CIBD) meetings, initiated in 1991, and to promote international collaborations across the cancer and bone field in both clinical and basic research.
Where appropriate CABS will partner with other societies that have an interest in bone and cancer. CABS believes these partnerships will enhance research and education in this rapidly developing area of biology and promote the translation of increasing scientific knowledge into clinical practice.
Our proposed Cancer and Bone scientific programme will present the most recent cutting edge advances in cancer-induced bone disease research and will provide an important opportunity for established and young investigators to network and present their newest research.
Learning Objectives:
On completion of the CABS programme, participants will enhance their understanding of:
• the importance of both the physical and cellular bone microenvironment and the hematopoietic stem cell niche in supporting the growth of metastatic cancer cells
• the role of cancer stem cells and hematopoietic stem cells in the metastatic process
• the current state of the field of genomics and proteomics as applied to bone metastasis
• the efficacy of new therapeutic agents and imaging techniques for bone cancers and bone metastasis
• the consequences of tumour cells on the skeleton
Additional details will be posted as soon as they are available.
Conference Overview (MolPharm):
The 2018 MolPharm Workshop is the 8th in a series that started in 2003. It is intended to provide a basis for understanding the molecular mechanisms of action of drugs known to act on the skeleton, and a rational basis for developing novel therapies in the future, based on some of the remarkable recent advances in the genetics and biology of bone and the musculoskeletal system.
The Workshop is interactive and international, with speakers who are leaders of their fields in academia and industry. The workshop is held at St Catherine’s College, Oxford. This delightful campus setting creates excellent opportunities for productive interactions among all participants.
For those who’ve attended before, you’ll know this means an exceptional meeting which combines cutting edge exciting science with a friendly and supportive atmosphere, and which encourages discussion and collaboration both in and out of the lecture theatre. Interaction between senior international scientists, clinicians and more junior researchers is particularly encouraged.
Learning Objectives:
To gain a better understanding of the molecular mechanisms of action of drugs already known to act on the skeleton
To discuss the rational basis for developing novel therapies in the future
To gain a better understanding of the development of drugs for the treatment of rare and common bone disorders
Conference Overview (CABS):
The primary mission of CABS is to formally run the cancer-induced bone disease (CIBD) meetings, initiated in 1991, and to promote international collaborations across the cancer and bone field in both clinical and basic research.
Where appropriate CABS will partner with other societies that have an interest in bone and cancer. CABS believes these partnerships will enhance research and education in this rapidly developing area of biology and promote the translation of increasing scientific knowledge into clinical practice.
Our proposed Cancer and Bone scientific programme will present the most recent cutting edge advances in cancer-induced bone disease research and will provide an important opportunity for established and young investigators to network and present their newest research.
Learning Objectives:
On completion of the CABS programme, participants will enhance their understanding of:
• the importance of both the physical and cellular bone microenvironment and the hematopoietic stem cell niche in supporting the growth of metastatic cancer cells
• the role of cancer stem cells and hematopoietic stem cells in the metastatic process
• the current state of the field of genomics and proteomics as applied to bone metastasis
• the efficacy of new therapeutic agents and imaging techniques for bone cancers and bone metastasis
• the consequences of tumour cells on the skeleton
Additional details will be posted as soon as they are available.
KEY DATES
30 Jun, 2018
Event Start Date
03 Jul, 2018
Event End Date
SPECIALITIES
Musculoskeletal RadiologyPharmacy and MedicineOncologySUGGESTED HOTELS
CONFERENCE VENUE
St Catherine's CollegeRELATED CONFERENCES & LIVE WEBINARS
Quick Links